Celebrating the best of pharma and recognizing companies that turn inspiration into innovation.
On Oct. 14, 2015, CPhI Worldwide announced the winners of the 2015 CPhI Pharma Awards. Entries for the 2015 awards included innovations and new service offerings from across the pharmaceutical supply chain and honored companies and individuals driving the industry forward. This year’s awards received a record number of entries and launched four new categories: ‘Best Innovation in Packaging’; ‘Best Innovation in Process and Formulation Development’; ‘Excellence in Partnering & Outsourcing’; ‘Best Innovation in APIs and Excipients’; ‘Innovation in Supply Chain & Logistic Management’; ‘Best Innovation in Manufacturing Technology’; and ‘CEO of the Year’.
The 16 finalists gave presentations on the first day of CPhI and the panel of judges, after extensive deliberations, announced the winners at a ceremony held Tuesday, Oct. 13.
The winners are:
CPhI Worldwide also presented an award to Novo Nordisk Pharmatech and Novozymes for the ‘most sustainable stand’. The stand is completely built out of modular systems, and its elements are reusable, resulting in almost no waste.
Rita Peters, CPhI jury member and editorial director of Pharmaceutical Technology and Pharmaceutical Technology Europe, commented, "On behalf of all the jury panel, I would like to thank the award finalists for their efforts to accelerate the development and manufacture of safe, effective, and cost-efficient therapies. Today, CPhI recognizes technologies, systems, and services that present new, innovative options for drug manufacturing; formulation and process developments; APIs and excipients; packaging; supply chain and logistics; and outsourcing. Finally, the Awards also represent substantial achievement in leadership through the CEO-of-the-year prize."
Rutger Oudejans, CPhI brand director, added, "Our judges spent the entire day rigorously interviewing all 16 finalists to ensure the most outstanding entries in each category were selected. But in the end, we had to pick just seven winners, a difficult task considering the quality of the entries. We are very lucky that our panel included many well-known and recognized professionals within the pharma industry who agreed to spend so much time and effort helping us recognize the industry’s most innovative and creative companies and individuals."
Oudejans continued, "What impresses me most are the innovative contributions that all the nominated companies are making in improving pharmaceutical processes, enhancing quality, and pushing new boundaries. On behalf of CPhI Worldwide and UBM EMEA, I would like to commend all of the finalists and offer my warmest congratulations to this year’s worthy winners.”
For more information on the CPhI Pharma Awards, please visit: http://www.cphi.com/awards/home
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.